|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 213/12 | |
| C07D 213/69 | |||
| C07D 213/78 | |||
| C07D 401/06 |
| (11) | Patento numeris | 3077376 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14866855.1 |
| Europos patento paraiškos padavimo data | 2014-12-02 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-10-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-10-16 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/068008 |
| Data | 2014-12-02 |
| (87) | Numeris | WO 2015/084763 |
| Data | 2015-06-11 |
| (30) | Numeris | Data | Šalis |
| 201361911686 P | 2013-12-04 | US | |
| 201462017542 P | 2014-06-26 | US |
| (72) |
CAO, Yang, US
GAUTHIER, Donald R. Jr., US
HUMPHREY, Guy R., US
ITOH, Tetsuji, US
JOURNET, Michel, US
QIAN, Gang, US
SHERRY, Benjamin D., US
TSCHAEN, David M., US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | PROCESS FOR MAKING REVERSE TRANSCRIPTASE INHIBITORS |
| PROCESS FOR MAKING REVERSE TRANSCRIPTASE INHIBITORS |